Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Seligdar commissioned a gold extraction plant in the Altai Territory

7/3/24 SELG

Ozon opened the third stage of the logistics complex in Zelenodolsk

7/3/24 OZON

LME to ban nickel supplies from Nornickel's Finnish plant

7/3/24 GMKN

Shareholders of European Eltech approved dividends for 2023

7/3/24 EELT

Zaimer opens a collection agency

7/3/24 ZAYM

Shareholders of KAMAZ approved dividends for 2023

7/3/24 KMAZ

Fix Price moved to Kazakhstan

7/3/24 FIXP

Shareholders of Sovcomflot approved dividends for 2023

7/3/24 FLOT

Sollers in the 1st half of the year increased sales in Russia by 41.2%

7/2/24 SVAV

Fix Price opened its 300th store in Kazakhstan

7/2/24 FIXP